Home » Topics » Regulatory » Patents

Patents
RSS

SmithKline Beecham develops Lp-PLA2 inhibitors for atherosclerosis

Jan. 20, 1998

MS&D reveals new class of antimigraine agents

Jan. 20, 1998

Lilly discloses new agents for influenza

Jan. 20, 1998

Novel semisynthetic macrolides prepared at Abbott

Jan. 20, 1998

Lilly discloses novel compounds for influenza

Jan. 19, 1998

Lilly reports new benzothiophenes for gynecological and other disorders

Jan. 19, 1998

Novartis reveals agents for atherosclerosis and chronic inflammation

Jan. 19, 1998

Merck & Co. claims carbapenems active against methicillin-resistant staphylococci

Jan. 19, 1998

Peptide HIV protease inhibitors claimed by Merck & Co.

Jan. 19, 1998

Thienopyridine derivatives for arthritis, osteoporosis from Takeda

Jan. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...